{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:31:32Z","timestamp":1768908692619,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["SNF 31003A_160216"],"award-info":[{"award-number":["SNF 31003A_160216"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00228-019-02720-2","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T23:03:40Z","timestamp":1565132620000},"page":"1491-1502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study"],"prefix":"10.1007","volume":"75","author":[{"given":"Victoria C.","family":"Ziesenitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Rodieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Borter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Bielicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Haschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs","family":"Duthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas O.","family":"Erb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"G\u00fcrtler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Holland-Cunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes N.","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Gotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"issue":"Suppl 4","key":"2720_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2165\/00003495-198600324-00006","volume":"32","author":"RN Brogden","year":"1986","unstructured":"Brogden RN (1986) Pyrazolone derivatives. Drugs 32(Suppl 4):60\u201370","journal-title":"Drugs"},{"issue":"6","key":"2720_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2165\/00002018-200427060-00005","volume":"27","author":"JR Laporte","year":"2004","unstructured":"Laporte JR, Ibanez L, Vidal X, Vendrell L, Leone R (2004) Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf Int J Med Toxicol Drug Exp 27(6):411\u2013420","journal-title":"Drug Saf Int J Med Toxicol Drug Exp"},{"issue":"3","key":"2720_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/bcpt.12312","volume":"116","author":"P Zapater","year":"2015","unstructured":"Zapater P, Llanos L, Barquero C, Bellot P, Pascual S, Carnicer F, Palazon JM, Gimenez P, Esteban A, Llorca L, Frances R, Horga JF, Such J (2015) Acute effects of dipyrone on renal function in patients with cirrhosis: a randomized controlled trial. Basic Clin Pharmacol Toxicol 116(3):257\u2013263","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"2720_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jcpt.12422","volume":"41","author":"S Andrade","year":"2016","unstructured":"Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J (2016) Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther 41(5):459\u2013477","journal-title":"J Clin Pharm Ther"},{"issue":"1\u20132","key":"2720_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.brainres.2005.04.083","volume":"1048","author":"E Vazquez","year":"2005","unstructured":"Vazquez E, Hernandez N, Escobar W, Vanegas H (2005) Antinociception induced by intravenous dipyrone (metamizol) upon dorsal horn neurons: involvement of endogenous opioids at the periaqueductal gray matter, the nucleus raphe magnus, and the spinal cord in rats. Brain Res 1048(1\u20132):211\u2013217","journal-title":"Brain Res"},{"issue":"1","key":"2720_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bmc.2011.11.028","volume":"20","author":"T Rogosch","year":"2012","unstructured":"Rogosch T, Sinning C, Podlewski A, Watzer B, Schlosburg J, Lichtman AH, Cascio MG, Bisogno T, Di Marzo V, Nusing R, Imming P (2012) Novel bioactive metabolites of dipyrone (metamizol). Bioorg Med Chem 20(1):101\u2013107","journal-title":"Bioorg Med Chem"},{"issue":"1\u20132","key":"2720_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0014-2999(02)01412-7","volume":"444","author":"D Alves","year":"2002","unstructured":"Alves D, Duarte I (2002) Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by dipyrone. Eur J Pharmacol 444(1\u20132):47\u201352","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2720_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2165\/00003088-199528030-00004","volume":"28","author":"M Levy","year":"1995","unstructured":"Levy M, Zylber-Katz E, Rosenkranz B (1995) Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet 28(3):216\u2013234","journal-title":"Clin Pharmacokinet"},{"key":"2720_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejps.2018.05.003","volume":"120","author":"F Bachmann","year":"2018","unstructured":"Bachmann F, Duthaler U, Rudin D, Krahenbuhl S, Haschke M (2018) N-demethylation of N-methyl-4-aminoantipyrine, the main metabolite of metamizole. Eur J Pharm Sci 120:172\u2013180","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"2720_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.bcp.2014.09.005","volume":"92","author":"C Martinez","year":"2014","unstructured":"Martinez C, Andreu I, Amo G, Miranda MA, Esguevillas G, Torres MJ, Blanca-Lopez N, Blanca M, Garcia-Martin E, Agundez JA (2014) Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole. Biochem Pharmacol 92(3):457\u2013466","journal-title":"Biochem Pharmacol"},{"key":"2720_CR11","unstructured":"Abdalla SO, Elouzi AA, Saad SE, Alem MD, Nagaah TA (2014) Study on the relationship between genetic polymorphisms of cytochrome CYP2C19 and metabolic bioactivation of dipyrone. J Chem Pharm Res (6)"},{"issue":"4","key":"2720_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/BF00549594","volume":"27","author":"M Levy","year":"1984","unstructured":"Levy M, Flusser D, Zylber-Katz E, Granit L (1984) Plasma kinetics of dipyrone metabolites in rapid and slow acetylators. Eur J Clin Pharmacol 27(4):453\u2013458","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"2720_CR13","first-page":"985","volume":"33","author":"P Rohdewald","year":"1983","unstructured":"Rohdewald P, Drehsen G, Milsmann E, Derendorf H (1983) Relationship between saliva levels of metamizol metabolites, bioavailability and analgesic efficacy. Arzneimittel-Forschung 33(7):985\u2013988","journal-title":"Arzneimittel-Forschung"},{"issue":"1","key":"2720_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2253-13-34","volume":"13","author":"E Caliskan","year":"2013","unstructured":"Caliskan E, Sener M, Kocum A, Ozyilkan NB, Ezer SS, Aribogan A (2013) The efficacy of intravenous paracetamol versus dipyrone for postoperative analgesia after day-case lower abdominal surgery in children with spinal anesthesia: a prospective randomized double-blind placebo-controlled study. BMC Anesthesiol 13(1):34","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"2720_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5935\/1808-8694.20130015","volume":"79","author":"AI Kocum","year":"2013","unstructured":"Kocum AI, Sener M, Caliskan E, Bozdogan N, Micozkadioglu D, Yilmaz I, Aribogan A (2013) Intravenous paracetamol and dipyrone for postoperative analgesia after day-case tonsillectomy in children: a prospective, randomized, double blind, placebo controlled study. Braz J Otorhinolaryngol 79(1):89\u201394","journal-title":"Braz J Otorhinolaryngol"},{"key":"2720_CR16","unstructured":"Sanofi Aventis (Suisse) SA (2017) Novalgin\u00ae - Summary of Product Characteristics (SPC). Last updated: November 2017. Accessible via URL http:\/\/www.swissmedicinfo.ch\/ . Accessed 28 May 2019"},{"issue":"3","key":"2720_CR17","first-page":"213","volume":"44","author":"A Balogh","year":"1989","unstructured":"Balogh A, Melzer K, Ziehl U, Finke G, Voigt L, Hoffmann A (1989) Elimination von Metamizol (Analgin\u00ae)-Metaboliten im Kindesalter. Z Klin Med 44(3):213\u2013215","journal-title":"Z Klin Med"},{"issue":"2","key":"2720_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF03189705","volume":"10","author":"G Asmardi","year":"1985","unstructured":"Asmardi G, Jamali F (1985) Pharmacokinetics of dipyrone in man; role of the administration route. Eur J Drug Metab Pharmacokinet 10(2):121\u2013125","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2720_CR19","unstructured":"Luus HG, Meyer BH, M\u00fcller FO, Swart KJ, Badian M (1989) Absolute bioavailability of dipyrone film tablets [abstract]. In: Eur J Clin Pharmacoled, ppA240:209.237"},{"issue":"10","key":"2720_CR20","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1177\/0091270011422812","volume":"52","author":"Y Wang","year":"2012","unstructured":"Wang Y, Jadhav PR, Lala M, Gobburu JV (2012) Clarification on precision criteria to derive sample size when designing pediatric pharmacokinetic studies. J Clin Pharmacol 52(10):1601\u20131606","journal-title":"J Clin Pharmacol"},{"issue":"S1","key":"2720_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10928-015-9432-2","volume":"42","author":"W Denney","year":"2015","unstructured":"Denney W, Duvvuri S, Buckeridge C (2015) Simple, automatic noncompartmental analysis: the PKNCA R package [abstract]. J Pharmacokinet Pharmacodyn 42(S1):11\u2013107 S165","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"2720_CR22","unstructured":"R Core Team (2014) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http:\/\/www.R-project.org\/ . Accessed 28 May 2019"},{"key":"2720_CR23","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use - ICH (2001)\u00a0ICH Topic E 11 Clinical Investigation of Medicinal Products in the Paediatric Population. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002926.pdf . Accessed 18 Aug 2016"},{"issue":"9","key":"2720_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2165\/00003088-200645090-00005","volume":"45","author":"TN Johnson","year":"2006","unstructured":"Johnson TN, Rostami-Hodjegan A, Tucker GT (2006) Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clin Pharmacokinet 45(9):931\u2013956","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"2720_CR25","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1124\/dmd.108.021873","volume":"36","author":"JC Stevens","year":"2008","unstructured":"Stevens JC, Marsh SA, Zaya MJ, Regina KJ, Divakaran K, Le M, Hines RN (2008) Developmental changes in human liver CYP2D6 expression. Drug Metabol Dispos Biol Fate Chem 36(8):1587\u20131593","journal-title":"Drug Metabol Dispos Biol Fate Chem"},{"issue":"4","key":"2720_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/jbt.20179","volume":"21","author":"RN Hines","year":"2007","unstructured":"Hines RN (2007) Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol 21(4):169\u2013175","journal-title":"J Biochem Mol Toxicol"},{"key":"2720_CR27","doi-asserted-by":"crossref","unstructured":"Duan P, Wu F, Moore JN, Fisher J, Crentsil V, Gonzalez D, Zhang L, Burckart GJ, Wang J (2019) Assessing CYP2C19 ontogeny in neonates and infants using physiologically based pharmacokinetic models: impact of enzyme maturation versus inhibition. CPT Pharmacometrics Syst Pharmacol 8(3):158\u2013166","DOI":"10.1002\/psp4.12350"},{"issue":"8","key":"2720_CR28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FPC.0000000000000062","volume":"24","author":"EM McDonagh","year":"2014","unstructured":"McDonagh EM, Boukouvala S, Aklillu E, Hein DW, Altman RB, Klein TE (2014) PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. Pharmacogenet Genomics 24(8):409\u2013425","journal-title":"Pharmacogenet Genomics"},{"issue":"13","key":"2720_CR29","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.1986.03380130077032","volume":"256","author":"The International Agranulocytosis and Aplastic Anemia Study","year":"1986","unstructured":"The International Agranulocytosis and Aplastic Anemia Study (1986) Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 256(13):1749\u20131757","journal-title":"JAMA"},{"issue":"4","key":"2720_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","volume":"58","author":"K Hedenmalm","year":"2002","unstructured":"Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58(4):265\u2013274","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"2720_CR31","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00228-004-0836-y","volume":"60","author":"L Ibanez","year":"2005","unstructured":"Ibanez L, Vidal X, Ballarin E, Laporte JR (2005) Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol 60(11):821\u2013829","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2720_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","volume":"71","author":"LS Blaser","year":"2015","unstructured":"Blaser LS, Tramonti A, Egger P, Haschke M, Krahenbuhl S, Ratz Bravo AE (2015) Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. Eur J Clin Pharmacol 71(2):209\u2013217","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"2720_CR33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00228-015-1895-y","volume":"71","author":"T Stammschulte","year":"2015","unstructured":"Stammschulte T, Ludwig WD, Muhlbauer B, Bronder E, Gundert-Remy U (2015) Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012. Eur J Clin Pharmacol 71(9):1129\u20131138","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2720_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/pan.13312","volume":"28","author":"VC Ziesenitz","year":"2018","unstructured":"Ziesenitz VC, Erb TO, Trachsel D, van den Anker JN (2018) Safety of dipyrone (metamizole) in children-what\u2019s the risk of agranulocytosis? Paediatr Anaesth 28(2):186\u2013187","journal-title":"Paediatr Anaesth"},{"key":"2720_CR35","doi-asserted-by":"crossref","unstructured":"Fieler M, Eich C, Becke K, Badelt G, Leimkuhler K, Messroghli L, Boethig D, Sumpelmann R (2015) Metamizole for postoperative pain therapy in 1177 children: a prospective, multicentre, observational, postauthorisation safety study. Eur J Anaesthesiol 32(12):839\u2013843","DOI":"10.1097\/EJA.0000000000000272"},{"issue":"10","key":"2720_CR36","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/EJA.0000000000000627","volume":"34","author":"T Stueber","year":"2017","unstructured":"Stueber T, Buessecker L, Leffler A, Gillmann HJ (2017) The use of dipyrone in the ICU is associated with acute kidney injury: a retrospective cohort analysis. Eur J Anaesthesiol 34(10):673\u2013680","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"2720_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00482-016-0160-3","volume":"31","author":"UM Stamer","year":"2017","unstructured":"Stamer UM, Gundert-Remy U, Biermann E, Erlenwein J, Meibetaner W, Wirz S, Stammschulte T (2017) Dipyrone (metamizole) : considerations on monitoring for early detection of agranulocytosis. Schmerz 31(1):5\u201313","journal-title":"Schmerz"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02720-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02720-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02720-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T07:23:41Z","timestamp":1664090621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02720-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2720"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02720-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"assertion":[{"value":"18 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"V.C.Z.: noneF.R.: noneA.A.: noneV.G.: noneC.B.: noneJ.A.B.: Her husband is a senior corporate counsel at Novartis International AG, Basel, Switzerland, and holds Novartis stock and stock options.M.H.: noneT.O.E.: noneU.D.: noneF.B.: noneN.G.: noneS.H.-C.: noneJ.N.v.d.A.: noneM.P. is a part-time consultant for Certara, L.P.The Division of Pediatric Pharmacology & Pharmacometrics of the University Children\u2019s Hospital Basel (M.P.) has received an unrestricted educational grant from Sanofi-Aventis Suisse SA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}